Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Rajesh Kumar's Stock Ratings
HSBC Analyst
Rajesh Kumar is an analyst at HSBC. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 10/13/2025
Overall Average Return
9.65%
Smart Score
Overall Average Return Percentile
56th
Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
10/09/2025 | IQV | IQVIA Hldgs | $198.17 | 18.59% | $195 → $235 | Upgrade | Hold → Buy | |||
10/02/2025 | NVO | Novo Nordisk | $57.57 | 21.59% | → $70 | Upgrade | Hold → Buy | |||
10/01/2025 | ABBV | AbbVie | $231.89 | — | — | Downgrade | Buy → Hold | |||
08/27/2025 | LLY | Eli Lilly | $841.22 | -16.79% | $675 → $700 | Upgrade | Reduce → Hold | |||
07/31/2025 | NVO | Novo Nordisk | $57.57 | — | — | Downgrade | Buy → Hold | |||
04/28/2025 | LLY | Eli Lilly | $841.22 | -16.79% | $1150 → $700 | Downgrade | Buy → Reduce | |||
04/25/2025 | KDP | Keurig Dr Pepper | $25.75 | 63.11% | $36 → $42 | Upgrade | Hold → Buy | |||
04/25/2025 | IQV | IQVIA Hldgs | $198.17 | -19.26% | $260 → $160 | Downgrade | Buy → Hold | |||
06/05/2024 | ABBV | AbbVie | $231.89 | -20.22% | → $185 | Upgrade | Hold → Buy | |||
04/30/2024 | TMO | Thermo Fisher Scientific | $512.00 | 30.86% | $660 → $670 | Maintains | Buy | |||
04/17/2024 | TMO | Thermo Fisher Scientific | $512.00 | 28.91% | $630 → $660 | Maintains | Buy | |||
04/17/2024 | DHR | Danaher | $202.00 | 38.61% | $250 → $280 | Upgrade | Hold → Buy | |||
04/04/2024 | UNH | UnitedHealth Group | $358.10 | 28.46% | → $460 | Upgrade | Reduce → Hold | |||
12/18/2023 | DHR | Danaher | $202.00 | — | — | Initiates | → Hold | |||
12/18/2023 | TEVA | Teva Pharmaceutical Indus | $20.39 | -36.24% | → $13 | Initiates | → Buy | |||
12/18/2023 | TMO | Thermo Fisher Scientific | $512.00 | 19.14% | → $610 | Initiates | → Buy | |||
12/18/2023 | ABBV | AbbVie | $231.89 | -32.73% | $167 → $156 | Downgrade | Buy → Hold | |||
12/18/2023 | UNH | UnitedHealth Group | $358.10 | 34.04% | $550 → $480 | Downgrade | Hold → Reduce | |||
10/27/2023 | BMY | Bristol-Myers Squibb | $44.07 | 20.26% | $55 → $53 | Upgrade | Reduce → Hold | |||
07/14/2023 | MRNA | Moderna | $27.13 | 257.54% | → $97 | Initiates | → Reduce | |||
07/14/2023 | BNTX | BioNTech | $103.85 | 19.4% | → $124 | Initiates | → Buy | |||
07/14/2023 | PFE | Pfizer | $24.89 | 100.88% | → $50 | Initiates | → Buy | |||
07/14/2023 | MRK | Merck & Co | $85.49 | 43.88% | → $123 | Initiates | → Hold | |||
07/14/2023 | LLY | Eli Lilly | $841.22 | -33.43% | → $560 | Initiates | → Buy | |||
07/14/2023 | BMY | Bristol-Myers Squibb | $44.07 | 27.07% | → $56 | Initiates | → Reduce | |||
07/14/2023 | ABBV | AbbVie | $231.89 | -27.98% | → $167 | Initiates | → Buy |
